ArdorComm Media Group

Sunday, March 1, 2026 8:02 PM

Health & Wellness Community

Indian Scientists Develop Breakthrough Nanomaterial to Stimulate Brain Cells Without Surgery

ardorcomm news

In a pioneering development, researchers at the Institute of Nano Science and Technology (INST), under the Department of Science and Technology (DST), have created a nanomaterial that can stimulate brain cells without the use of electrodes, lasers, or magnetic devices. The material, known as graphitic carbon nitride (g-C₃N₄), has shown the ability to enhance neuron growth, communication, and dopamine production. Significantly, it also helped reduce harmful proteins associated with Parkinson’s disease in animal models, offering a potential breakthrough in non-invasive therapies for neurological disorders. Unlike current treatments such as deep brain stimulation (DBS), which require surgical implants, g-C₃N₄ interacts naturally with neurons. Acting like a smart semiconductor switch, it generates subtle electric fields in response to neuronal activity, opening calcium channels that encourage healthy cell growth and connectivity. The INST team confirmed their hypothesis through extensive tests, including Ca²⁺ imaging studies, gene expression analysis, and immunofluorescence assays, proving the material’s unique ability to modulate neurons without fatigue. Lead researcher Dr. Manish Singh described it as the first evidence of semiconducting nanomaterials directly influencing neuronal behavior without external triggers. He noted that the findings could transform treatments for Alzheimer’s, Parkinson’s, and brain injuries, while also laying the foundation for futuristic applications like brain-inspired computing using lab-grown brain organoids. Although more preclinical and clinical studies are required, the discovery signals a paradigm shift in neuromodulation and tissue engineering, with immense therapeutic potential for an ageing global population increasingly affected by neurodegenerative diseases. Source: PIB

Indian Scientists Develop Breakthrough Nanomaterial to Stimulate Brain Cells Without Surgery Read More »

Govt Aims to Meet WHO’s 1:1000 Doctor-Patient Ratio, Says NMC Chairman Abhijat Sheth

ardorcomm news

The government is determined to increase the number of doctors across India in a uniform manner to meet the World Health Organization’s (WHO) standard of a 1:1000 doctor-patient ratio, National Medical Commission (NMC) Chairman Abhijat Sheth said on Saturday. Speaking at the 11th convocation of the Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital in New Delhi, Sheth congratulated the graduating doctors, their families, and faculty members for their commitment to the medical profession. He underlined the government’s efforts to not only bridge the doctor-patient gap but also to achieve a balanced undergraduate-to-postgraduate (UG-PG) ratio of 1:1, which would bring India’s healthcare standards closer to those of developed nations. Sheth also highlighted initiatives by the NMC and the National Board of Examinations in Medical Sciences, including the integration of skill-based training, virtual learning, and competency-driven education alongside traditional methods. He urged students to focus on their health, resilience, and continuous learning throughout their careers. Addressing the graduating batch, Director General of Health Services (DGHS) Dr. Sunita Sharma reminded them that receiving a medical degree comes with a profound responsibility — to heal, lead, and serve. She emphasized that whether in clinical practice, research, or teaching, doctors must let their work be guided by empathy, evidence, and excellence. Calling medicine a noble calling rooted in compassion, she encouraged young doctors to stay humble and grounded as they advance in their professional journeys. Source: PTI

Govt Aims to Meet WHO’s 1:1000 Doctor-Patient Ratio, Says NMC Chairman Abhijat Sheth Read More »

IMA Andhra Pradesh joins hands with US research centre to tackle urinary tract diseases

ardorcomm news

The Andhra Pradesh chapter of the Indian Medical Association (IMA-AP) has partnered with Ipseity, a US-based research centre, to conduct an in-depth study on urinary tract diseases. Highlighting the growing concern, IMA-AP president Dr. G. Nanda Kishore said that chronic urinary tract conditions, especially recurring infections, pose a serious public health challenge. He noted that many antibiotics currently used in treatment are failing to fully eradicate infections, leaving patients vulnerable to repeated urinary tract infections (UTIs). As part of the initiative, urine samples from 300 chronic UTI patients across Andhra Pradesh will be collected for advanced testing. These will include molecular PCR and antimicrobial resistance (AMR) profiling, aimed at identifying the most effective antibiotics for complete recovery. According to Dr. Kishore, the study could play a crucial role in reducing both health risks and financial strain on patients. He also urged doctors across the state to actively support the programme. Dr. Sandeep Nadendla, CEO of Ipseity and a native of Andhra Pradesh, said his mission is to bring advanced diagnostic solutions and medical research closer to the local population. He stressed that collaboration between practicing doctors and research institutions is key to ensuring early detection and better treatment outcomes for diseases affecting communities. Source: TNN

IMA Andhra Pradesh joins hands with US research centre to tackle urinary tract diseases Read More »

Chronic Disease Deaths Rising in India, Women Face Higher Risk: Lancet Report

ardorcomm news

India has recorded a troubling rise in deaths from chronic illnesses such as heart disease, diabetes, and cancer, with women disproportionately affected, according to a new global analysis published in The Lancet. The study, led by researchers at Imperial College London in collaboration with the World Health Organization (WHO), assessed the probability of dying from non-communicable diseases (NCDs) before the age of 80 across 185 countries. Findings show that while 4 out of 5 countries witnessed a decline in premature mortality linked to chronic conditions between 2010 and 2019, India — along with Papua New Guinea — bucked the trend, reporting increases for both men and women. Alarmingly, Indian women experienced a steeper rise in risk compared to men. “Heart disease and diabetes were major contributors to India’s increase in deaths from chronic illnesses,” the researchers noted. By contrast, nations such as China, Egypt, Nigeria, Russia, and Brazil reported reductions in NCD-related mortality for both sexes. Globally, declines in deaths from cancers and cardiovascular conditions were offset by increases in fatalities caused by dementia, alcohol use disorders, and pancreatic and liver cancers. The findings are significant in the context of the UN’s Sustainable Development Goal to reduce premature mortality from NCDs by one-third by 2030. Researchers warn that without urgent investment and targeted interventions, India risks falling further behind in tackling its chronic disease burden. The report comes just ahead of the UN General Assembly’s high-level meeting on September 25, where world leaders will revisit global strategies to prevent and control NCDs, as well as promote mental health and well-being. Source: PTI Photo Credit: iStock  

Chronic Disease Deaths Rising in India, Women Face Higher Risk: Lancet Report Read More »

Russia Declares Cancer Vaccine ‘Enteromix’ Ready for Clinical Use; To Be Provided Free for Patients

ardorcomm news

Russia has announced that its personalised cancer vaccine, Enteromix, developed using advanced mRNA technology, is now ready for clinical application following successful early trials. The vaccine, created by the National Medical Research Radiology Centre in collaboration with the Engelhardt Institute of Molecular Biology, was unveiled at the 10th Eastern Economic Forum in Vladivostok in September 2025, attracting global interest from 8,400 delegates representing 75 countries. Personalised Immunotherapy Unlike chemotherapy and radiation, which damage healthy cells alongside cancerous ones, Enteromix works by training the body’s immune system to recognise and destroy tumors. Each dose is tailored to a patient’s RNA profile, ensuring a highly individualised treatment with fewer side effects. The vaccine uses four harmless viral vectors to trigger immune responses that shrink tumors, slow their spread, and extend life expectancy. Clinical Trial Results In early-stage clinical trials involving 48 patients, Enteromix demonstrated strong results: Tumor sizes reduced by 60–80%. Tumor growth halted and in some cases reversed. Improved overall survival rates. No severe side effects reported. Effectiveness maintained across multiple doses. The initial version of Enteromix targets colorectal cancer, a leading cause of cancer-related deaths worldwide. Further versions for glioblastoma (brain cancer) and melanoma are also under development. Accessibility and Global Impact Russia’s Federal Medical and Biological Agency (FMBA), led by Veronika Skvortsova, confirmed that once regulatory approvals are secured, the vaccine will be distributed free of cost to patients, making advanced cancer therapy more accessible across all social groups. Enteromix is part of a growing global race to develop cancer vaccines using mRNA technology. Companies like BioNTech and Moderna are advancing similar personalised vaccines for pancreatic, lung, and skin cancers, while the UK’s Cancer Vaccine Launch Pad and India’s work on breast, oral, and cervical cancer vaccines show worldwide momentum in this field. Russia, however, is among the first to declare clinical readiness. Next Steps Despite promising results, Enteromix must undergo Phase 2 and Phase 3 clinical trials involving larger patient groups to confirm its safety and effectiveness before widespread use. Approval from Russia’s Ministry of Health and international health agencies will be critical for its rollout. If successful, Enteromix could become one of the first personalised mRNA cancer vaccines available to the public, offering a major breakthrough in global oncology treatment. Source: TOI Photo Credit: @SputnikInt/X   

Russia Declares Cancer Vaccine ‘Enteromix’ Ready for Clinical Use; To Be Provided Free for Patients Read More »

Cycling Could Help Slow Parkinson’s Progression, Says Neurologist from CMC Vellore

Cycling may do much more than strengthen the body—it could also help protect the brain in people living with Parkinson’s disease. Dr. Sudhir Kumar, a Hyderabad-based neurologist trained at CMC Vellore, highlighted new research published in Clinical Neurophysiology (2025), which shows that regular cycling can significantly benefit patients with Parkinson’s. “Cycling is not only fun and effective but also a powerful way to support movement, mood, and overall quality of life,” he said. The study observed patients with Parkinson’s who used deep-brain stimulation devices while training on specialized stationary bikes. These bikes either assisted or resisted pedaling, maintaining a steady pace of around 80 revolutions per minute for half an hour, several times weekly. Within weeks, participants showed improved brain activity related to motor control—evidence of enhanced neuroplasticity, the brain’s ability to form new connections. According to Dr. Kumar, cycling helps beyond building muscle strength. Regular aerobic exercise can ease hallmark symptoms of Parkinson’s—such as tremors, stiffness, and slow movement—while also improving balance, posture, and reducing risks of freezing of gait. Additionally, it may slow disease progression by boosting protective brain chemicals like BDNF, which support neuron survival and repair. Practical advice for patients: Stationary or motor-assisted bikes are the safest options; outdoor cycling may be considered if balance is stable, with proper precautions. Target 30 minutes of moderate-to-vigorous cycling at least three times a week. Complement cycling with strength training, yoga or tai chi for balance, and stretching for flexibility. “Movement truly is medicine,” Dr. Kumar said, underscoring that each pedal stroke is more than exercise—it’s a step toward rewiring the brain for improved control, strength, and independence. What is Parkinson’s Disease? Parkinson’s disease (PD) is a progressive neurological disorder caused by the loss of dopamine-producing nerve cells in the substantia nigra region of the brain. Dopamine is critical for smooth, coordinated movement. By the time symptoms appear, 60–80% of these neurons are typically damaged or lost. In addition to dopamine loss, Parkinson’s also affects norepinephrine-producing cells, which regulate automatic body functions, explaining fatigue, blood pressure fluctuations, and other non-motor issues. Clumps of a protein called alpha-synuclein (Lewy bodies) are commonly found in affected brain cells, though their exact role in cell death remains under study. Symptoms of Parkinson’s: Motor symptoms: hand tremors, muscle rigidity, slowness of movement (bradykinesia), postural imbalance, and the classic shuffling gait. Non-motor symptoms: depression, anxiety, sleep disturbances, memory decline, urinary problems, speech/swallowing difficulties, muscle pain, fatigue, and sexual dysfunction. Since the condition progresses differently in each patient, early diagnosis and holistic care—including medication, physiotherapy, and lifestyle strategies—play a vital role in maintaining quality of life. Source: Economic Times

Cycling Could Help Slow Parkinson’s Progression, Says Neurologist from CMC Vellore Read More »

AIIMS Gorakhpur to Launch New Academic Courses

AIIMS Gorakhpur has announced the introduction of several new academic programmes, marking a major step towards academic expansion, advanced medical training, and strengthening research at the institute. The approvals were finalized during the 8th meeting of the Standing Academic Committee. The newly sanctioned courses include DM programmes in neurology, pain medicine, clinical pharmacology, and critical care medicine (under the Department of Anaesthesia, Pain Medicine & Critical Care). Additionally, Post-Doctoral Certificate Courses (PDCC) have been approved in trauma anaesthesia, spine trauma, pelvic-acetabular surgery, and adolescent gynaecology. Significantly, some of these, such as the PDCC in adolescent gynaecology, are the first of their kind in India. A Post-Doctoral Fellowship in maternal-foetal medicine (under the Department of Obstetrics & Gynaecology) has also been introduced. Further, new courses like MS in Trauma Surgery, PhD in Nursing, MSc in Nursing Psychology, and BSc in Operation Theatre Technology have been sanctioned. During the meeting, the institute’s Executive Director, Dr. Ashoka Jahnavi Prasad, highlighted the growing concern of student suicides across institutions. He stressed the urgent need for psychological support and preventive interventions. He further noted that launching specialised courses like MSc in Nursing Psychology will help build a stronger mental health workforce and make psychological care more accessible for students and the wider community. Source: TNN

AIIMS Gorakhpur to Launch New Academic Courses Read More »

AIIMS study reveals high prevalence of catheter-related infections in Indian hospitals

A nationwide study led by the All India Institute of Medical Sciences (AIIMS), New Delhi, has revealed that bloodstream infections linked to catheter use are widespread in intensive care units (ICUs) across India, with many cases caused by highly drug-resistant microbes. These hospital-acquired infections, known as Central Line-Associated Bloodstream Infections (CLABSI), occur when a catheter inserted into a large vein becomes contaminated. According to estimates published in The Lancet Global Health, Indian ICUs report nearly nine infection events for every 1,000 days a central line remains in use. The AIIMS-led team analysed seven years of data collected by the Indian Healthcare-Associated Infections (HAI) surveillance network, spanning 200 ICUs across 54 hospitals. Between May 2017 and April 2024, the network recorded 8,629 confirmed CLABSI cases, covering more than 3 million patient-days and nearly 1 million central line-days. The pooled CLABSI rate was found to be 8.83 per 1,000 central line-days. The study also observed a spike in infection rates during 2020–21, coinciding with the COVID-19 pandemic. Researchers attributed this surge to overburdened ICUs, staff shortages, and lapses in infection prevention practices. Experts stressed that while CLABSI is preventable, establishing systematic infection surveillance and prevention programs requires significant resources—a major challenge for low- and middle-income countries like India. Nevertheless, the findings mark the first large-scale, standardised surveillance report on CLABSI in India, offering a foundation for healthcare systems to adopt quality improvement measures. Source: PTI Photo Credit: AFP  

AIIMS study reveals high prevalence of catheter-related infections in Indian hospitals Read More »

Daily Almond Intake of 60 Grams Found to Shield DNA and Combat Oxidative Stress

Almonds may be more than just a crunchy snack — they could be a powerful ally in protecting your health at the cellular level. New research suggests that consuming at least 60 grams of almonds a day can significantly reduce oxidative stress and safeguard DNA from damage. Oxidative stress, caused by an overload of harmful free radicals, accelerates aging, inflammation, and chronic disease risk. Almonds, rich in vitamin E, antioxidants, flavonoids, and healthy fats, act as natural defenders, helping neutralize these free radicals and strengthening the body’s resilience. According to the study, individuals who included over 60 grams of almonds in their daily diet showed notable improvements in antioxidant activity and reduced markers of oxidative stress. This directly translates into better DNA protection, healthier cells, and potentially slower signs of aging. Earlier clinical evidence also supports this. A landmark randomized trial with young male smokers who consumed 84 g of almonds daily recorded a 28% drop in oxidative DNA damage, a 34% reduction in lipid peroxidation, and a 23% decline in DNA strand breaks, proving almonds’ protective benefits even under high-stress conditions. The “60 g threshold” is now being recognized as a key benchmark. That’s about 40–45 almonds per day, roughly two servings — enough for the bioactive compounds in almonds to activate their strongest protective effects. While smaller amounts still offer health benefits, crossing this intake level seems to unlock greater antioxidant potential. Beyond heart and brain health, almonds are emerging as a natural superfood for DNA protection. Their vitamin E helps shield cell membranes, while polyphenols and flavonoids reduce inflammation and support vascular health. Together, they slow down cellular wear and tear linked to aging, cancer, diabetes, and cardiovascular disease. Experts emphasize that consistency is crucial. Incorporating almonds daily — whether eaten raw, roasted, blended into smoothies, or sprinkled over meals — makes it easy to hit the 60 g mark. This growing body of evidence reinforces almonds as more than a nutritious snack: they are a long-term investment in wellness, helping preserve genetic material, reduce disease risks, and support healthier aging. Source: TOI

Daily Almond Intake of 60 Grams Found to Shield DNA and Combat Oxidative Stress Read More »

IISc Study Warns of Bird Flu Strain’s Rising Threat to Humans

Researchers at the Indian Institute of Science (IISc) have raised concerns that the currently circulating H5N1 bird flu strain could be evolving to pose a greater risk to humans. The team, led by Kesavardhana Sannula from the Department of Biochemistry, found that the 2.3.4.4b clade of H5N1 carries genetic mutations similar to those seen in past pandemic influenza strains, enhancing its ability to adapt to human hosts. The study revealed that viruses capable of infecting foxes may have a higher human adaptation potential than those infecting cattle — a surprising finding. H5N1, first detected in birds about 30 years ago, has since caused sporadic human infections and widespread fatalities in birds and mammals, making it a panzootic concern. Using computational analysis of thousands of protein sequences from birds, mammals, and human influenza viruses, the researchers identified mutations concentrated in the viral polymerase complex (PA, PB2), nucleoproteins, and haemagglutinin (HA) proteins — key elements that could aid the virus in crossing the species barrier. The findings underscore the need for heightened surveillance and preparedness to mitigate potential outbreaks. Source: Indian Express

IISc Study Warns of Bird Flu Strain’s Rising Threat to Humans Read More »